Manufacturers/Mannkind Corporation

Mannkind Corporation

6 drugs in NADAC|0 Generic,6 Brand

Mannkind Corporation lists 6 NDCs in the CMS NADAC file (0 generic, 6 brand), at an average NADAC of $10.40 per unit, with a week-over-week move of +0.5% across products that moved. The firm's full portfolio, pricing trend are listed below.

Total Drugs

6

0G / 6B

Avg Price / Unit

$10.3975

$5.21 – $15.65

Avg 7d Change

+0.47%

Across 1 drugs with changes

7d Activity

1↑5 flat

of 6 total drugs

Portfolio Price Trend

Monthly average NADAC price across all drugs

Keep following this manufacturer

These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.

Frequently Asked Questions

How many drugs does Mannkind Corporation make?

Mannkind Corporation lists 6 NDCs in the CMS NADAC file — 0 generic and 6 brand products.

What is the average price of Mannkind Corporation drugs?

The average NADAC across Mannkind Corporation's portfolio is $10.3975 per unit, ranging from $5.2055 to $15.6530.

What types of drugs does Mannkind Corporation make?

Mannkind Corporation makes drugs across 1 FDA pharmacologic class. The most common by NDC count are Insulin (3).

Has Mannkind Corporation had any drug recalls?

No FDA enforcement recalls are matched to Mannkind Corporation in the openFDA feed.

How has Mannkind Corporation's pricing changed recently?

Over the past 7 days, 1 Mannkind Corporation product rose and 0 fell, with a portfolio-wide average change of +0.5%.

Drug Portfolio

6 drugs total, 6 shown

Drug ↕Price 7d Change ↕
AFREZZA (REGULAR INSULIN) 12 UNIT CARTRIDGE
INSULIN HUMAN
$15.6530
per EA
—
AFREZZA (REGULAR INSULIN) 90-8 UNIT / 90-12 UNIT
INSULIN HUMAN
$13.0377
per EA
—
AFREZZA ((REGULAR INSULIN) 8 UNIT CARTRIDGE
INSULIN HUMAN
$10.3754
per EA
—
AFREZZA (REGULAR INSULIN) 60-4 UNIT/60-8 UNIT/60-12 UNIT
INSULIN HUMAN
$10.3329
per EA
—
AFREZZA (REGULAR INSULIN) 90-4 UNIT / 90-8 UNIT
INSULIN HUMAN
$7.7805
per EA
—
AFREZZA (REGULAR INSULIN) 4 UNIT CARTRIDGE
INSULIN HUMAN
$5.2055
per EA
+0.47%